PuSH - Publication Server of Helmholtz Zentrum München

Graesser, C.* ; Krefting, J.* ; Schwab, M.* ; Scheidhauer, H.* ; Novacek, S.* ; Armbruster, N.L.* ; Hinterdobler, J.* ; Rapelius, S.* ; Romer, A.* ; Rumpf, P.M.* ; Roski, F.* ; Lenz, T.* ; Voll, F.* ; Vilne, B.* ; Trenkwalder, T.* ; von Scheidt, M.* ; Xhepa, E.* ; Joner, M.* ; Cassese, S.* ; Steffens, S. ; Weber, C.* ; Schunkert, H.* ; Ndrepepa, G.* ; Kastrati, A.* ; Kessler, T.* ; Moggio, A.* ; Sager, H.B.*

Prolonged inflammation associates with greater infarct size and poor outcome after ST-segment elevation myocardial infarction.

JACC-Basic Transl. Sci. 11:101563 (2026)
Publ. Version/Full Text DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
AIMS: Acute myocardial infarction (MI) induces a systemic inflammatory response that usually resolves within days, but the prognostic impact of persistent inflammation is uncertain. We assessed whether sustained leukocytosis after ST-segment elevation myocardial infarction (STEMI) relates to infarct size, left ventricular function, and clinical outcomes. METHODS AND RESULTS: In >1,700 STEMI patients treated with primary percutaneous coronary intervention, leukocytes peaked on admission and typically normalized by day 3. Patients were stratified by leukocyte tertiles at admission and day 3. High day 3 leukocyte counts were associated with larger infarct size (scintigraphy; peak creatine kinase-myocardial band and troponin T), worse left ventricular function in hospital and at 6 months, and higher 1- and 5-year mortality. Patients whose leukocyte counts declined had better recovery, whereas persistent leukocytosis marked the poorest outcomes. Monocyte RNA sequencing showed post-MI transcriptomic reprogramming, and murine MI models recapitulated a similar systemic immune response. CONCLUSIONS: Persistent inflammation, particularly elevated leukocyte counts at day 3 post-MI, is associated with adverse remodeling and increased mortality after STEMI, identifying unresolved inflammation as a negative prognostic marker and potential therapeutic target.
Altmetric
Additional Metrics?
[➜Log in]
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Keywords Stemi ; Inflammation ; Leukocytes ; Resolution Of Inflammation ; Risk Stratification
ISSN (print) / ISBN 2452-302X
e-ISSN 2452-302X
Journal JACC: Basic to Translational Science
Quellenangaben Volume: 11, Issue: 7, Pages: , Article Number: 101563 Supplement: ,
Publisher Elsevier
Reviewing status Peer reviewed
Institute(s) Institute of Diabetes and Cancer (IDC)